---
$id: https://graph.org.ai/products/commodity/51433919
$type: Product
source: UNSPSC
code: "51433919"
title: "Lercanidipine"
class: "51433900"
classTitle: "Antihypertensive pyridines"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lercanidipine

**UNSPSC Code**: 51433919
**Class**: [Antihypertensive pyridines](Antihypertensive pyridines.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a calcium channel blocker with the molecular formula C36H41N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V7XTJ4R0BH, chemically known as (+-)-2-((3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate but generally known as lercanidipine, which bears US NIH Compound Identifier 65866. European Medicines Agency schedules Lercanidipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08437MIG. The term LERCANIDIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). World Health Organization schedules lercanidipine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule lercanidipine under HS 29333999 and SITC 51574. As of Q4 2014, LERCANIDIPINE remains the US FDA Preferred Term for this commodity. Lercanidipine bears US NLM identifiers UMLS ID C0526399 and NCI Concept Code C81687. SMILES: O(C(CN(CCC(c1ccccc1)c1ccccc1)C)(C)C)C(=O)C1=C(NC(=C(C1c1cc([N](=O)O)ccc1)C(=O)OC)C)C.

